Peng et al. reported that the abnormally expressed glycolytic enzymes, in particular the type-II hexokinase (HKII) and aldolase B (ALDOB), were associated with advanced HCC, dismal prognostic outcome, and early tumor recurrence (ETR). Here, HK2 is linked to hepatocellular carcinoma.